In a report released today, Anthony Vendetti from Maxim Group maintained a Hold rating on Cutera (CUTR). The company’s shares closed yesterday at $13.27, close to its 52-week low of $13.09.
Vendetti said:
“Market open, CUTR reported lower-than-expected preliminary 4Q18 revenue. The company also announced the resignation of CEO James Reinstein amid Board dissatisfaction with 2018 operational results and stock price performance. CUTR plans to report full 4Q18 results on Market close.”
According to TipRanks.com, Vendetti is a 4-star analyst with an average return of 3.1% and a 49.6% success rate. Vendetti covers the Healthcare sector, focusing on stocks such as Restoration Robotics Inc, Xtant Medical Holdings, and Ra Medical Systems Inc.
Currently, the analyst consensus on Cutera is a Moderate Buy with an average price target of $28.50, representing an 114.8% upside. In a report issued on January 2, Stifel Nicolaus also maintained a Hold rating on the stock with a $17 price target.
.
See today’s analyst top recommended stocks >>
The company has a one-year high of $56.05 and a one-year low of $13.09. Currently, Cutera has an average volume of 234K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cutera, Inc. is a global medical device company, which engages in the design, development, manufacture, marketing and servicing of laser and other energy based aesthetics systems for practitioners. Its products include Enlighten, TruSculpt, Excel HR, Excel V, and Xeo.
